Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: Are there specific patient characteristics or biomarkers to indicate response to treatment? - Kocaturk, E.; Baskan, E. B.; Engin, B.; Ozdemir, M.; KÜÇÜK, ÖZLEM SU; SU KÜÇÜK, ÖZLEM; Can, P.; Ornek, S.; Hasal, E.; Atakan, N. (My University, 2019)
Keywords: Kocaturk E., Baskan E. B. , Engin B., Ozdemir M., KÜÇÜK Ö. S. , Can P., Ornek S., Hasal E., Atakan N., -Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: Are there specific patient characteristics or biomarkers to indicate response to treatment?-, Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Lisbon, Portekiz, 1 - 05 Haziran 2019, cilt.74, ss.484-485